IL166822A0 - 6,7-dihydro-5h-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines - Google Patents

6,7-dihydro-5h-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines

Info

Publication number
IL166822A0
IL166822A0 IL16682205A IL16682205A IL166822A0 IL 166822 A0 IL166822 A0 IL 166822A0 IL 16682205 A IL16682205 A IL 16682205A IL 16682205 A IL16682205 A IL 16682205A IL 166822 A0 IL166822 A0 IL 166822A0
Authority
IL
Israel
Prior art keywords
dihydro
interleukin
inflammatory cytokines
aüpyrazol
whichcontrol
Prior art date
Application number
IL16682205A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL166822A0 publication Critical patent/IL166822A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL16682205A 2002-09-18 2005-02-10 6,7-dihydro-5h-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines IL166822A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/246,214 US6730668B2 (en) 2001-09-20 2002-09-18 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
PCT/US2003/008477 WO2004026878A1 (en) 2002-09-18 2003-03-18 6,7-DIHYDRO-5H-PYRAZOLO[1,2-a]PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY CYTOKINES

Publications (1)

Publication Number Publication Date
IL166822A0 true IL166822A0 (en) 2006-01-15

Family

ID=32028948

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16682205A IL166822A0 (en) 2002-09-18 2005-02-10 6,7-dihydro-5h-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines

Country Status (20)

Country Link
US (3) US6730668B2 (xx)
EP (1) EP1539761B1 (xx)
JP (1) JP2006502189A (xx)
KR (3) KR20070087684A (xx)
CN (1) CN1315834C (xx)
AT (1) ATE429434T1 (xx)
AU (1) AU2003218280B8 (xx)
BR (1) BR0314292A (xx)
CA (1) CA2496500A1 (xx)
DE (1) DE60327328D1 (xx)
ES (1) ES2322046T3 (xx)
IL (1) IL166822A0 (xx)
MA (1) MA27434A1 (xx)
MX (1) MXPA05002984A (xx)
NO (1) NO20051686L (xx)
NZ (1) NZ538197A (xx)
PL (1) PL376086A1 (xx)
RU (1) RU2289584C2 (xx)
WO (1) WO2004026878A1 (xx)
ZA (1) ZA200501590B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566357B1 (en) * 2001-09-20 2003-05-20 The Procter & Gamble Co. Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7326714B2 (en) * 2001-09-20 2008-02-05 The Procter & Gamble Company 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6849627B2 (en) * 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
CA2760911A1 (en) * 2009-05-19 2010-11-25 George E. Davis Compounds and methods for controlling fungi
US10512628B2 (en) 2016-04-24 2019-12-24 Solano S.P. Ltd. Dinotefuran liquid flea and tick treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124982A (en) 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529153A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US6472416B1 (en) * 1999-08-27 2002-10-29 Abbott Laboratories Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
US6566357B1 (en) * 2001-09-20 2003-05-20 The Procter & Gamble Co. Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
MA27434A1 (fr) 2005-07-01
KR20070087684A (ko) 2007-08-28
BR0314292A (pt) 2005-12-13
US6960593B2 (en) 2005-11-01
EP1539761B1 (en) 2009-04-22
ZA200501590B (en) 2006-02-22
CN1681819A (zh) 2005-10-12
CA2496500A1 (en) 2004-04-01
DE60327328D1 (de) 2009-06-04
KR20070051374A (ko) 2007-05-17
AU2003218280A1 (en) 2004-04-08
WO2004026878A1 (en) 2004-04-01
US6730668B2 (en) 2004-05-04
KR20050057444A (ko) 2005-06-16
RU2005111220A (ru) 2006-02-27
US7368455B2 (en) 2008-05-06
JP2006502189A (ja) 2006-01-19
NZ538197A (en) 2007-01-26
AU2003218280B2 (en) 2008-05-15
CN1315834C (zh) 2007-05-16
EP1539761A1 (en) 2005-06-15
NO20051686L (no) 2005-04-05
US20030134867A1 (en) 2003-07-17
PL376086A1 (en) 2005-12-12
AU2003218280B8 (en) 2008-06-26
KR100842191B1 (ko) 2008-06-30
ES2322046T3 (es) 2009-06-16
US20040058944A1 (en) 2004-03-25
RU2289584C2 (ru) 2006-12-20
US20050282844A1 (en) 2005-12-22
ATE429434T1 (de) 2009-05-15
MXPA05002984A (es) 2005-06-22

Similar Documents

Publication Publication Date Title
ZA200501590B (en) 6,7-Dihydro-5H-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines.
WO2004094388A3 (en) Indazole derivatives as jnk inhibitors
NO20054959D0 (no) Fremgangsmater for behandling av interleukin-6 relaterte sykdommer
NO20073932L (no) Fuserte bicykliske karboksamidderivater for anvendelse som CXCR2 inhibitorer i behandlingen av inflammasjon
MXPA03008955A (es) Agente terapeutico para enfermedades de tipo artritides cronicas o enfermedades relacionadas con la ninez.
WO2001087328A3 (en) Interleukin-1 inhibitors in the treatment of diseases
WO2008064321A3 (en) Methods of treating chronic inflammatory diseases using a gm-csf antagonist
MXPA04006555A (es) Piridazinodionas-3,4-disustituidas como antagonistas de receptor de quimiocina cxc.
SI1725544T1 (sl) 3-(4-heterociklil-1,2,3-triazol-1-il)-N-aril-benzamidi kot inhibitorji proizvodnje citokinov za zdravljenje kroničnih vnetnih bolezni
MY149577A (en) Cytokine inhibitors
IS2690B (is) 5-fenýl-4-metýl-þíasól-2-ýl-amínafleiður sem hemlar fosfatídýlínósítól 3 kínasaensíma (PI3) til að meðhöndla bólgusjúkdóma í öndunarvegi
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE235239T1 (de) 2-substituierte aryl-pyrrolen, zusammensetzungen solche verbindungen enthaltend und deren verwendung
CA2492804A1 (en) Novel inhibitors of kinases
MXPA04001187A (es) Receptores de interleucina-1 en el tratamiento de enfermedades.
HRP20070020T3 (en) 1-(2h-pyrazol-3-yl)-3- 4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl -urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
WO2006087644A3 (en) Macrolides with anti-inflammatory activity
EA200801711A1 (ru) Пролекарства возбуждающих аминокислот
NO20065762L (no) Prodroger av pyrrolypyrimidin-ERK-proteinkinaseinhibitorer.
SI1747220T1 (sl) Substituirani 1H-pirolo(3,2-b, 3,2-c in 2,3-c)piridin-2-karboksamidi in sorodni analogi kot inhibitorji kazein kinaze I epsilon
PT1562954E (pt) Antagonistas de ccr1 para o tratamento da doenca desmielinzante inflamatoria i.a.
AU2003265924A1 (en) Benzimidazolones and their use as cytokine inhibitors
EA200100876A3 (ru) Фармацевтическая композиция для предупреждения или лечения заболевания, связанного с избыточным продуцированием il-12
SE0302666D0 (sv) Novel Compounds